Assignee
MCLEAY MATTHEW
US·2 granted patents·2 pending applications·6 citations·filing 2021–2024
Top patents by PatentIndex Score
4 records- 0191US11446244B2Compositions containing verteporfin, ribavirin, gemcitabine, or combinations thereof and methods of use for treating COVID-19, cancer, or non cancer diseasesMCLEAY MATTHEW·Filed 2021·Granted Sep 20, 2022·4 cites·16 claims
- 0290US11918598B2Compositions containing Verteporfin, Ribavirin, Gemcitabine, or combinations thereof and methods of use for treating COVID-19, cancer, or non cancer diseasesMCLEAY MATTHEW·Filed 2022·Granted Mar 5, 2024·2 cites·2 claims
- 0380US2024252525A1Compositions containing verteporfin, ribavirin, gemcitabine, or combinations thereof and methods of use for treating covid-19, cancer, or non cancer diseasesMCLEAY MATTHEW·Filed 2024·Application pending·0 cites
- 0470US2021228485A1Compositions Containing Verteporfin, Ribavirin, Gemcitabine, or Combinations Thereof and Methods of Use for Treating COVID-19, Cancer, or Non Cancer DiseasesMCLEAY MATTHEW·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MCLEAY MATTHEW files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →